glp 1 zepbound tirzepatide Non-Surgical Medical Weight Loss in Bellevue FDA approval for Zepbound (tirzepatide)
Description
In my clinical experience, many patients who plateau on semaglutide see renewed progress after transitioning to tirzepatide, although individual results vary and treatment decisions should always be guided by a medical provider
The most common side effects were gastrointestinal issues such as nausea, diarrhea, and vomiting, which were generally mild to moderate
This is a significant risk factor, possibly due to changes in blood pressure and oxygen levels at night
Clinical trial averages describe groups of patients
